- AU$19.27m
- AU$15.86m
- AU$0.27m
Brief: Pathkey.Ai Announces A$2.8 Million Placement
Brief: Pathkey.AI Seeks Trading Halt Pending Capital Raising Announcement
Brief: Pathkey.AI Appoints Andrew Farnsworth As CEO
Australia's Pathkey.AI soars on deal to buy semiconductor developer
Brief: Pathkey.AI To Acquire AI Semiconductor Design Verification Platform
Brief: Pathkey.AI Requests Trading Halt
Australia's Pathkey.AI falls on discounted placement
Brief: Pathkey.AI Says A$2.5 Million Placement Successfully Completed At A$0.012 Per Share
Brief: Pathkey.Ai Seeks Trading Halt
Brief: Pathkey.AI Says Saurabh Jain Steps Down As Executive Chairman
Australia's Pathkey.AI rises after upgrade in its AI clinical trial platform
Brief: Opyl Ltd Signs Services Agreement With Innovatrix
Brief: Opyl Signs Agreements With Netherlands-Based Cardialysis And UK-Based Evestia Clinical
Brief: Opyl Completes A$1.5M Oversubscribed Placement
Brief: Opyl Seeks Trading Halt
Brief: Opyl Ltd Announces Partnership With Avion
Brief: Opyl Signs JV With X Firm
Australia's AI firm Opyl rises on joint venture to expand market penetration
Brief: Opyl Partners L39 Capital To Launch Ai-Powered Biotech Fund